PL402939A1 - Kompozycja 3-0-deacylo-4'-monofosforylolipidu A - Google Patents

Kompozycja 3-0-deacylo-4'-monofosforylolipidu A

Info

Publication number
PL402939A1
PL402939A1 PL402939A PL40293902A PL402939A1 PL 402939 A1 PL402939 A1 PL 402939A1 PL 402939 A PL402939 A PL 402939A PL 40293902 A PL40293902 A PL 40293902A PL 402939 A1 PL402939 A1 PL 402939A1
Authority
PL
Poland
Prior art keywords
composition
monophosphoryl lipid
desacyl
mla
salmonella
Prior art date
Application number
PL402939A
Other languages
English (en)
Polish (pl)
Inventor
Kent R. Myers
Snyder D. Scott
Original Assignee
Corixa Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Corixa Corporation filed Critical Corixa Corporation
Publication of PL402939A1 publication Critical patent/PL402939A1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C07H13/02—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
    • C07H13/04—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals attached to acyclic carbon atoms
    • C07H13/06—Fatty acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/04—Polysaccharides, i.e. compounds containing more than five saccharide radicals attached to each other by glycosidic bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55572—Lipopolysaccharides; Lipid A; Monophosphoryl lipid A

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • Virology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
PL402939A 2001-03-30 2002-03-28 Kompozycja 3-0-deacylo-4'-monofosforylolipidu A PL402939A1 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US28008901P 2001-03-30 2001-03-30

Publications (1)

Publication Number Publication Date
PL402939A1 true PL402939A1 (pl) 2013-08-19

Family

ID=23071615

Family Applications (2)

Application Number Title Priority Date Filing Date
PL402939A PL402939A1 (pl) 2001-03-30 2002-03-28 Kompozycja 3-0-deacylo-4'-monofosforylolipidu A
PL373657A PL217737B1 (pl) 2001-03-30 2002-03-28 Sposób wytwarzania kompozycji lipopolisacharydu

Family Applications After (1)

Application Number Title Priority Date Filing Date
PL373657A PL217737B1 (pl) 2001-03-30 2002-03-28 Sposób wytwarzania kompozycji lipopolisacharydu

Country Status (21)

Country Link
US (3) US20030031684A1 (enExample)
EP (3) EP1461418B1 (enExample)
JP (3) JP4233327B2 (enExample)
KR (2) KR100884462B1 (enExample)
CN (2) CN1928107B (enExample)
AU (1) AU2002306962B2 (enExample)
BR (2) BR122015016711B8 (enExample)
CA (1) CA2440249C (enExample)
CZ (2) CZ305565B6 (enExample)
DK (2) DK2465937T3 (enExample)
ES (2) ES2415769T3 (enExample)
HU (1) HU228688B1 (enExample)
IL (3) IL157867A0 (enExample)
MX (1) MXPA03008856A (enExample)
NZ (2) NZ548595A (enExample)
PL (2) PL402939A1 (enExample)
PT (2) PT2465937E (enExample)
RU (2) RU2302463C2 (enExample)
SI (2) SI1461418T1 (enExample)
WO (1) WO2002078637A2 (enExample)
ZA (1) ZA200307238B (enExample)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030031684A1 (en) 2001-03-30 2003-02-13 Corixa Corporation Methods for the production of 3-O-deactivated-4'-monophosphoryl lipid a (3D-MLA)
FR2848223B1 (fr) * 2002-12-09 2005-02-25 Centre Nat Rech Scient Nouveau procede d'isolement des endotoxines.
TWI457133B (zh) 2005-12-13 2014-10-21 Glaxosmithkline Biolog Sa 新穎組合物
PL3017827T3 (pl) 2005-12-22 2019-04-30 Glaxosmithkline Biologicals Sa Szczepionka z koniugatem polisacharydu pneumokokowego
GB0607088D0 (en) 2006-04-07 2006-05-17 Glaxosmithkline Biolog Sa Vaccine
BRPI0721393B8 (pt) * 2007-03-22 2022-09-06 Fund Butantan método para obter lipídeo a monofosforilado da bordetella pertussis como um subproduto da produção de vacina celular contra coqueluche
US20090035360A1 (en) 2007-05-24 2009-02-05 Dominique Ingrid Lemoine Lyophilised antigen composition
US20130066064A1 (en) * 2010-05-20 2013-03-14 Glaxosmithkline Biologicals S.A, Novel process
BR112013029514A2 (pt) 2011-05-17 2019-09-24 Glaxosmithkline Biologicals Sa composição imunogênica, vacina, e, método de tratar ou impedir uma doença
GB201113570D0 (en) 2011-08-05 2011-09-21 Glaxosmithkline Biolog Sa Vaccine
US9241988B2 (en) * 2012-04-12 2016-01-26 Avanti Polar Lipids, Inc. Disaccharide synthetic lipid compounds and uses thereof
CN102746414B (zh) * 2012-07-20 2014-04-16 成都生物制品研究所有限责任公司 一种细菌脂多糖的沉降方法
GB201518684D0 (en) 2015-10-21 2015-12-02 Glaxosmithkline Biolog Sa Vaccine
US11186652B2 (en) 2015-12-22 2021-11-30 Glaxosmithkline Biologicals Sa LPS extraction process
KR101761348B1 (ko) * 2016-01-06 2017-07-26 한국과학기술연구원 헥사 아실화된 모노포스포릴 지질 a를 생산하는 세균, 및 이를 이용한 헥사 아실화된 모노포스포릴 지질 a 생산 방법
KR102019331B1 (ko) * 2017-07-05 2019-09-09 한국과학기술연구원 모노포스포릴 지질 ａ를 구성적으로 생산하는 세균, 및 이를 이용한 모노포스포릴 지질 ａ 생산 방법
EP3777884A1 (en) 2019-08-15 2021-02-17 GlaxoSmithKline Biologicals S.A. Immunogenic composition
KR102748233B1 (ko) * 2019-08-29 2024-12-31 주식회사 유바이오로직스 모노포스포릴 지질 ａ를 생산하는 방법
WO2021040414A1 (ko) * 2019-08-29 2021-03-04 주식회사 유바이오로직스 모노포스포릴 지질 ａ를 생산하는 방법
WO2021122551A1 (en) 2019-12-19 2021-06-24 Glaxosmithkline Biologicals Sa S. aureus antigens and compositions thereof
CN113652455B (zh) * 2021-08-09 2022-04-26 北京华诺泰生物医药科技有限公司 六酰基3d-mla的发酵方法
CN116554361B (zh) * 2023-07-11 2023-11-03 江苏瑞科生物技术股份有限公司 用于提取脂多糖的抽提液和方法

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5A (en) * 1836-08-10 Thomas Blanchard Machine for mortising solid wooden shells of ships' tackle-blocks
JPS5758889A (en) * 1980-08-19 1982-04-08 Shell Int Research Preparation of microbiological polysaccharide
US4436727A (en) 1982-05-26 1984-03-13 Ribi Immunochem Research, Inc. Refined detoxified endotoxin product
US4436728A (en) * 1982-05-26 1984-03-13 Ribi Immunochem Research, Inc. Refined detoxified endotoxin product
US5057598A (en) * 1983-05-06 1991-10-15 Centocor, Inc. Monoclonal antibodies reactive with endotoxin core
US4612304A (en) * 1985-06-11 1986-09-16 Ss Pharmaceutical Co., Ltd. Antitumor formulation containing lipopolysaccharide with trehalose derivatives
US5554372A (en) * 1986-09-22 1996-09-10 Emory University Methods and vaccines comprising surface-active copolymers
US4912094B1 (en) 1988-06-29 1994-02-15 Ribi Immunochem Research Inc. Modified lipopolysaccharides and process of preparation
US5068191A (en) * 1989-08-31 1991-11-26 The Biomembrane Institute Purified histo-blood group a glycosyltransferase and antibodies thereto
US5552141A (en) * 1991-10-30 1996-09-03 Ribi; Hans O. Polymeric immunological adjuvants
EP0761231B1 (en) 1992-06-25 2000-01-12 SMITHKLINE BEECHAM BIOLOGICALS s.a. Vaccine composition containing adjuvants
RU2051969C1 (ru) * 1992-07-31 1996-01-10 Иркутский научно-исследовательский противочумный институт Сибири и Дальнего Востока Способ получения бактериальных липополисахаридов
ES2162139T5 (es) 1993-03-23 2008-05-16 Smithkline Beecham Biologicals S.A. Composiciones de vacuna que contienen monofosforil-lipido a 3-o-desacilado.
GB9326253D0 (en) 1993-12-23 1994-02-23 Smithkline Beecham Biolog Vaccines
US5648343A (en) * 1994-02-28 1997-07-15 The University Of Georgia Research Foundation Method for treating LPS-mediated disorders
UA56132C2 (uk) 1995-04-25 2003-05-15 Смітклайн Бічем Байолоджікалс С.А. Композиція вакцини (варіанти), спосіб стабілізації qs21 відносно гідролізу (варіанти), спосіб приготування композиції вакцини
US5762943A (en) * 1996-05-14 1998-06-09 Ribi Immunochem Research, Inc. Methods of treating type I hypersensitivity using monophosphoryl lipid A
US5855913A (en) * 1997-01-16 1999-01-05 Massachusetts Instite Of Technology Particles incorporating surfactants for pulmonary drug delivery
US5985309A (en) * 1996-05-24 1999-11-16 Massachusetts Institute Of Technology Preparation of particles for inhalation
US5846789A (en) * 1996-12-10 1998-12-08 Council Of Scientific And Industrial Research Process for preparing nontoxic lipopolysaccharides from acidiphilium species
JP3595966B2 (ja) * 1996-12-25 2004-12-02 カウンシィル オブ サイアンティフィック アンド インダストリアル リサーチ 内毒血症または敗血症の予防に有効な新規の効力のある非毒性リポ多糖体の調製方法
US6491919B2 (en) * 1997-04-01 2002-12-10 Corixa Corporation Aqueous immunologic adjuvant compostions of monophosphoryl lipid A
CA2284586C (en) 1997-04-01 2011-02-08 Ribi Immunochem Research, Inc. Aqueous immunologic adjuvant compositions of monophosphoryl lipid a
JP2002513773A (ja) * 1998-05-07 2002-05-14 コリクサ コーポレイション アジュバント組成物及びその使用法
DE10013539B4 (de) * 2000-03-20 2006-07-13 Pharma-Zentrale Gmbh Lipopolysaccharide aus Escherichia coli, Verfahren zu deren Herstellung und deren Verwendungen
US20030031684A1 (en) * 2001-03-30 2003-02-13 Corixa Corporation Methods for the production of 3-O-deactivated-4'-monophosphoryl lipid a (3D-MLA)

Also Published As

Publication number Publication date
US9512159B2 (en) 2016-12-06
CZ20032895A3 (cs) 2004-02-18
CA2440249C (en) 2013-07-09
ES2517391T3 (es) 2014-11-03
ES2415769T3 (es) 2013-07-26
CN1928107A (zh) 2007-03-14
KR100884462B1 (ko) 2009-02-20
HUP0304091A3 (en) 2011-04-28
BRPI0208535B8 (pt) 2021-05-25
KR20060015704A (ko) 2006-02-20
MXPA03008856A (es) 2003-12-04
EP2465937B1 (en) 2014-08-13
NZ528204A (en) 2006-12-22
WO2002078637A9 (en) 2004-01-15
JP2004535477A (ja) 2004-11-25
US20030031684A1 (en) 2003-02-13
BR122015016711B8 (pt) 2021-07-27
US20140243513A1 (en) 2014-08-28
ZA200307238B (en) 2005-08-31
WO2002078637A3 (en) 2004-07-22
JP2008255335A (ja) 2008-10-23
HUP0304091A2 (hu) 2004-03-29
HK1165494A1 (en) 2012-10-05
IL157867A0 (en) 2004-03-28
JP4233327B2 (ja) 2009-03-04
CA2440249A1 (en) 2002-10-10
PT1461418E (pt) 2013-07-09
PL373657A1 (en) 2005-09-05
JP2012057170A (ja) 2012-03-22
IL189651A0 (en) 2008-06-05
CZ305601B6 (cs) 2015-12-30
CN1608127A (zh) 2005-04-20
EP2465937A1 (en) 2012-06-20
KR20080088666A (ko) 2008-10-02
EP2479280A1 (en) 2012-07-25
BR122015016711B1 (pt) 2016-08-02
PT2465937E (pt) 2014-11-03
HK1104319A1 (en) 2008-01-11
RU2427378C2 (ru) 2011-08-27
BR0208535A (pt) 2006-02-21
BRPI0208535B1 (pt) 2016-03-29
CN100577790C (zh) 2010-01-06
NZ548595A (en) 2008-04-30
EP1461418A2 (en) 2004-09-29
IL157867A (en) 2011-07-31
DK2465937T3 (da) 2014-11-10
EP1461418A4 (en) 2006-05-17
HK1075913A1 (zh) 2005-12-30
HU228688B1 (en) 2013-05-28
AU2002306962B2 (en) 2008-04-24
KR100927099B1 (ko) 2009-11-13
JP5730178B2 (ja) 2015-06-03
EP1461418B1 (en) 2013-04-24
SI1461418T1 (sl) 2013-08-30
RU2302463C2 (ru) 2007-07-10
PL217737B1 (pl) 2014-08-29
AU2002306962A2 (en) 2002-10-15
SI2465937T1 (sl) 2014-11-28
RU2003131677A (ru) 2005-04-20
IL189651A (en) 2011-02-28
CZ305565B6 (cs) 2015-12-16
US20070212758A1 (en) 2007-09-13
CN1928107B (zh) 2010-12-22
DK1461418T3 (da) 2013-07-08
WO2002078637A2 (en) 2002-10-10
RU2006140606A (ru) 2008-05-27

Similar Documents

Publication Publication Date Title
PL402939A1 (pl) Kompozycja 3-0-deacylo-4'-monofosforylolipidu A
PL344012A1 (en) Novel substituted cyclic compounds, preparation method and pharmaceutical compositions containing them
AU698620B2 (en) Hydrophilated dental impression compounds
BG103485A (en) Ketobanzamides as calpain inhibitors
PT2277536T (pt) Purificação de polissacáridos capsulares bacterianos
JO2654B1 (en) Multiple aryl caroxa amides are useful as lipid - lowering agents
NZ319131A (en) Herbicidal mixtures having a synergistic effect
EP1438074A4 (en) ADJUVANT COMPOSITIONS
AU3115395A (en) Dihydrobenzofuranes
EP2039699A3 (en) Extractive methods for purifying sucralose
PL349426A1 (en) Compositions comprising 1,1,1,3,3-pentafluorobutane and use of said compositions
NZ279397A (en) Mercaptoacetylamido 1,3,4,5-tetrahydro-benzo[c]azepin-3-one disulfide derivatives and pharmaceutucal compositions
IT1293778B1 (it) 1,4,7,10-tetraazabiciclo(8.2.2.)tetradecan-2 one, sua preparazione e suo uso per la preparazione di tetraazamacrocicli
PL345448A1 (en) Substituted phenyl uracils
TW349095B (en) Taxoids, their preparation and pharmaceutical compositions which contain them
AU3051499A (en) Oral antimicrobial and anti-odor compositions
EP1398306A3 (en) A (1'R, 2'S, 5'R)-3-l-Menthoxyalkan-1-ol cooling sensate
MXPA02009215A (es) Lipopolisacaridos extraidos de escherichia coli.
CA2442210A1 (en) Aryl oxime-piperazines useful as ccr5 antagonists
ITMI20020303A0 (it) Dispositivo di pescaggio dell'olio per compressore ermetico
EP1004654A3 (en) Adjuvants and methods for raising intracellular calcium ion concentration
ZA949562B (en) Conjugates of hirudin and lipophilic compounds
AU2002315612A1 (en) Fragrance and flavour compositions
ES2162126T3 (es) Nuevos taxoides, su preparacion y las composiciones farmaceuticas que les contienen.
AU2910800A (en) Novel substituted 3-phenoxy and 3-phenylalkyloxy-2-phenyl-propylamines

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)